C
Cabaletta Bio, Inc.
CABA · NASDAQ · Healthcare · 448M
Closing price
$1.93
-1.03% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.8×
Enterprise value / EBITDAEV/EBITDA
-0.9×
Free cash flow yieldFCF yield
-67.0%
Return on equityROE
-149.8%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
-85.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.